Sign Up to like & get
recommendations!
1
Published in 2022 at "JAMA Network Open"
DOI: 10.1001/jamanetworkopen.2022.0035
Abstract: This cross-sectional study evaluates the representation of women as authors of pivotal trials of novel cardiovascular drugs approved by the US Food and Drug Administration between 2008 and 2020.
read more here.
Keywords:
representation women;
novel cardiovascular;
pivotal trials;
authors pivotal ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2017.05.027
Abstract: BACKGROUND Heart failure (HF) with reduced ejection fraction remains a major therapeutic challenge. The aim of this study was to investigate the role of novel cardiovascular biomarkers, i.e. soluble suppression of tumorigenicity (sST2), growth-differentiation factor-15…
read more here.
Keywords:
cardiovascular biomarkers;
novel cardiovascular;
heart;
heart failure ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Heart"
DOI: 10.1136/heartjnl-2021-319055
Abstract: Cardiovascular clinicians are increasingly expected not only to optimise their patients’ health outcomes, but also to control costs and ensure the judicious use of healthcare resources. Clinicians must therefore have a rigorous understanding of costeffectiveness…
read more here.
Keywords:
cardiovascular therapies;
novel cardiovascular;
effectiveness affordability;
affordability novel ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Cardiovascular diagnosis and therapy"
DOI: 10.21037/cdt.2018.12.08
Abstract: Cortistatin (CST) is a small molecule bioactive peptide containing an FWKT tetramer. It is widely distributed in nervous, immune and endocrine systems. Many studies have shown that CST can exert many biological effects, for example:…
read more here.
Keywords:
cortistatin;
cardiovascular diseases;
peptide;
cortistatin novel ... See more keywords